CN112353707A - Face cream and preparation method thereof - Google Patents
Face cream and preparation method thereof Download PDFInfo
- Publication number
- CN112353707A CN112353707A CN202011370386.7A CN202011370386A CN112353707A CN 112353707 A CN112353707 A CN 112353707A CN 202011370386 A CN202011370386 A CN 202011370386A CN 112353707 A CN112353707 A CN 112353707A
- Authority
- CN
- China
- Prior art keywords
- parts
- phase
- cream
- palmitoyl
- main kettle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims abstract description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 24
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims abstract description 16
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 10
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 8
- MFYAQFYIDXXKQG-MLCQCVOFSA-N (2s)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-2-(hexadecanoylamino)-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]propanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O MFYAQFYIDXXKQG-MLCQCVOFSA-N 0.000 claims abstract description 8
- YHHHHJCAVQSFMJ-FNORWQNLSA-N (3e)-deca-1,3-diene Chemical compound CCCCCC\C=C\C=C YHHHHJCAVQSFMJ-FNORWQNLSA-N 0.000 claims abstract description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 8
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims abstract description 8
- 240000000912 Macadamia tetraphylla Species 0.000 claims abstract description 8
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims abstract description 8
- 108010075308 N-palmitoyl-seryl-seryl-asparaginyl-alanine Proteins 0.000 claims abstract description 8
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 8
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 8
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 8
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 8
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000010466 nut oil Substances 0.000 claims abstract description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000008390 olive oil Nutrition 0.000 claims abstract description 8
- 239000004006 olive oil Substances 0.000 claims abstract description 8
- 229920000515 polycarbonate Polymers 0.000 claims abstract description 8
- 239000004417 polycarbonate Substances 0.000 claims abstract description 8
- 229940057910 shea butter Drugs 0.000 claims abstract description 8
- 229920002545 silicone oil Polymers 0.000 claims abstract description 8
- 229940032094 squalane Drugs 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229920001503 Glucan Polymers 0.000 claims abstract description 7
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940081733 cetearyl alcohol Drugs 0.000 claims abstract description 7
- 235000005206 Hibiscus Nutrition 0.000 claims abstract description 3
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims abstract description 3
- 244000284380 Hibiscus rosa sinensis Species 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- 230000001815 facial effect Effects 0.000 claims 1
- 230000003712 anti-aging effect Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 241000131460 Plectranthus Species 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- DNRJTBAOUJJKDY-UHFFFAOYSA-N 2-Acetyl-3,5,5,6,8,8-hexamethyl-5,6,7,8- tetrahydronaphthalene Chemical compound CC(=O)C1=C(C)C=C2C(C)(C)C(C)CC(C)(C)C2=C1 DNRJTBAOUJJKDY-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241001504226 Hoodia Species 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 235000017277 hoodia Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a face cream which comprises the following components in parts by weight: phase A: 0.2-0.3 part of decadiene cross-linked polymer; 18-22 parts of water; phase B: 0.4-0.8 parts of fucoidin; 0.05-0.08 part of fermented olive oil; and (3) phase O: 0.5-0.8 part of hydrogenated polydecene; 0.5-0.8 part of squalane; 0.5-0.8 part of macadamia nut oil; 1-1.5 parts of shea butter; 0.2-0.5 part of mixed alcohol; 0.15-0.5 part of cyclopentadimethylsiloxane and/or cyclohexasiloxane; 0.2-0.4 part of dimethyl silicone oil; 0.1-0.3 part of cetearyl alcohol; hydrogenated lecithin 0.1-0.3; 1-1.5 of glycerol stearate; phase W: 0.004-0.008 parts of hyaluronic acid; 1-1.5 parts of propylene glycol; 1-1.5 parts of butanediol; 0.1-0.5 part of glucan; phase H: 0.2-0.4 parts of Hibiscus thunbergii extract; 0.1-0.2 parts of palmitoyl tripeptide, palmitoyl tetrapeptide and/or palmitoyl pentapeptide; 0.01-0.03 part of essence; 0.01-0.02 part of potassium hydroxide; 1-1.5 parts of polycarbonate. The face cream has the advantages of anti-aging, skin color spot lightening, mellow and non-greasy, and neat and clear appearance.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a face cream.
Background
With the development of economy, the pace of work and life is accelerated, the working pressure of the female life is increased, various electronic products do not need to be used in work and life, at present, various electronic products have certain radiation, and in addition to the overnight habit and incorrect skin care common sense, more and more women have dry skin, dark skin color and color spots, so that the skin health of the female can be seriously influenced, the skin is aged more quickly, and the quality of life is further reduced.
Disclosure of Invention
In view of the above-mentioned defects of the prior art, the technical problem to be solved by the present invention is to provide a skin cream which can resist aging and lighten skin color spots, and is mellow, not greasy, clean and clear.
In order to achieve the purpose, the invention provides a face cream which comprises the following components in parts by weight: phase A: 0.2-0.3 part of decadiene cross-linked polymer; 18-22 parts of water; phase B: 0.4-0.8 parts of fucoidin; 0.05-0.08 part of fermented olive oil; and (3) phase O: 0.5-0.8 part of hydrogenated polydecene; 0.5-0.8 part of squalane; 0.5-0.8 part of macadamia nut oil; 1-1.5 parts of shea butter; 0.2-0.5 part of mixed alcohol; 0.15-0.5 part of cyclopentadimethylsiloxane and/or cyclohexasiloxane; 0.2-0.4 part of dimethyl silicone oil; 0.1-0.3 part of cetearyl alcohol; hydrogenated lecithin 0.1-0.3; 1-1.5 of glycerol stearate; phase W: 0.004-0.008 parts of hyaluronic acid; 1-1.5 parts of propylene glycol; 1-1.5 parts of butanediol; 0.1-0.5 part of glucan; phase H: 0.2-0.4 parts of Hibiscus thunbergii extract; 0.1-0.2 parts of palmitoyl tripeptide, palmitoyl tetrapeptide and/or palmitoyl pentapeptide; 0.01-0.03 part of essence; 0.01-0.02 part of potassium hydroxide; 1-1.5 parts of polycarbonate.
Further, in the phase a, decadiene crosslinked polymer 0.264 parts, water 20.7968 parts.
Further, in the phase B, 0.64 part of fucoidin and 0.064 part of fermented olive oil are added.
Further, in the O phase, 0.64 part of hydrogenated polydecene, 0.64 part of squalane, 0.64 part of macadamia nut oil, 1.28 parts of shea butter, 0.32 part of mixed alcohol, 0.32 part of cyclopenta dimethyl silicone and/or cyclohexasiloxane, 0.32 part of dimethyl silicone oil, 0.16 part of cetostearyl alcohol, 0.16 part of hydrogenated lecithin, and 1.28 parts of glyceryl stearate.
Further, in the W phase, 0.0064 parts of hyaluronic acid, 1.28 parts of propylene glycol, 1.28 parts of butylene glycol, and 0.32 parts of dextran.
Furthermore, in the H phase, 0.32 part of the tonalid extract repair peptide, 0.16 part of palmitoyl tripeptide and/or palmitoyl tetrapeptide and/or palmitoyl pentapeptide, 0.016 part of essence, 0.0128 part of potassium hydroxide and 1.28 parts of polycarbonate.
A preparation method of the face cream comprises the following steps:
(1) adding the phase A into a main kettle, uniformly stirring and completely dissolving, adding the phase W into the main kettle, stirring and dissolving, adding the phase O into the main kettle, and heating the main kettle to 80-85 ℃;
(2) maintaining the temperature of the main kettle at 80-85 ℃, and preserving the temperature for 20 minutes;
(3) cooling the main kettle to 60 ℃, adding the phase B, and stirring for 10 minutes;
(4) cooling the main kettle to 45 ℃, adding the H material, and stirring for 10 minutes;
(5) then the pH value is measured to be qualified after the temperature is reduced to 36 ℃, and the material is discharged.
Further, in the step (5), the qualified pH value is 3.5-6.3.
The invention has the beneficial effects that: the skin care product has mellow and non-greasy texture, is transparent and clear, and has the effects of fading color spots, enabling the skin to be white day by day and restoring the glittering and translucent by the added polypeptide component and the black algae extract playing a role in repairing peptide.
Detailed Description
Example one
The face cream comprises the following components in parts by weight:
phase A: 0.2 part of decadiene cross-linked polymer;
18 parts of water;
phase B: 0.4 part of fucoidin;
0.05 part of fermented olive oil;
and (3) phase O: 0.5 part of hydrogenated polydecene;
0.5 part of squalane;
0.5 part of macadamia nut oil;
1 part of shea butter;
0.2 part of mixed alcohol, wherein the mixed alcohol is mixed alcohol of sixteen to eighteen parts;
0.15 part of cyclopentadimethylsiloxane and/or cyclohexasiloxane;
0.2 part of dimethyl silicone oil;
0.1 part of cetearyl alcohol;
0.1 part of hydrogenated lecithin;
1 part of glycerol stearate;
phase W: 0.004 portion of hyaluronic acid;
1 part of propylene glycol;
1 part of butanediol;
0.1 part of glucan;
phase H: 0.2 part of plectranthus nigricans extract polypeptide;
0.1 part of palmitoyl tripeptide, palmitoyl tetrapeptide and/or palmitoyl pentapeptide;
0.01 part of essence;
0.01 part of potassium hydroxide;
1 part of polycarbonate.
Example two
The face cream is characterized by comprising the following components in parts by weight: phase A: 0.3 part of decadiene cross-linked polymer;
22 parts of water;
phase B: 0.8 part of fucoidin;
0.08 part of fermented olive oil;
and (3) phase O: 0.8 part of hydrogenated polydecene;
0.8 part of squalane;
0.8 part of macadamia nut oil;
1.5 parts of shea butter;
0.5 part of mixed alcohol, wherein the mixed alcohol is mixed alcohol of sixteen to eighteen parts;
0.5 part of cyclopentadimethylsiloxane and/or cyclohexasiloxane;
0.4 part of dimethyl silicone oil;
0.3 part of cetearyl alcohol;
0.3 part of hydrogenated lecithin;
1.5 parts of glycerol stearate;
phase W: 0.008 parts of hyaluronic acid;
1.5 parts of propylene glycol;
1.5 parts of butanediol;
0.5 part of glucan;
phase H: 0.4 part of plectranthus nigricans extract polypeptide;
0.2 parts of palmitoyl tripeptide, palmitoyl tetrapeptide and/or palmitoyl pentapeptide;
0.03 part of essence;
0.02 part of potassium hydroxide;
1.5 parts of polycarbonate.
EXAMPLE III
The face cream is characterized by comprising the following components in parts by weight: phase A: 0.264 part of decadiene cross-linked polymer;
20.7968 parts of water;
phase B: 0.64 part of fucoidin;
0.064 part of fermented olive oil;
and (3) phase O: 0.64 part of hydrogenated polydecene;
0.64 part of squalane;
0.64 parts of macadamia nut oil;
1.28 parts of shea butter;
0.32 part of mixed alcohol, wherein the mixed alcohol is mixed alcohol of sixteen to eighteen parts;
0.32 part of cyclopentadimethylsiloxane and/or cyclohexasiloxane;
0.32 part of dimethyl silicone oil;
0.16 part of cetearyl alcohol;
0.16 part of hydrogenated lecithin;
1.28 parts of glycerol stearate;
phase W: 0.0064 parts of hyaluronic acid;
1.28 parts of propylene glycol;
1.28 parts of butanediol;
0.32 part of glucan;
phase H: 0.32 parts of Hoodia nigricans extract polypeptide;
0.16 parts of palmitoyl tripeptide, palmitoyl tetrapeptide and/or palmitoyl pentapeptide;
0.016 parts of essence;
0.0128 part of potassium hydroxide;
polycarbonate 1.28 parts.
A preparation method of the face cream comprises the following steps according to the formula of the first embodiment to the third embodiment:
(1) adding the phase A into a main kettle, uniformly stirring and completely dissolving, adding the phase W into the main kettle, stirring and dissolving, adding the phase O into the main kettle, and heating the main kettle to 80-85 ℃;
(2) maintaining the temperature of the main kettle at 80-85 ℃, and preserving the temperature for 20 minutes;
(3) cooling the main kettle to 60 ℃, adding the phase B, and stirring for 10 minutes;
(4) cooling the main kettle to 45 ℃, adding the H material, and stirring for 10 minutes;
(5) then the pH value is measured to be qualified after the temperature is reduced to 36 ℃, and the qualified pH value is 3.5-6.3.
The foregoing detailed description of the preferred embodiments of the invention has been presented. It should be understood that numerous modifications and variations could be devised by those skilled in the art in light of the present teachings without departing from the inventive concepts. Therefore, the technical solutions available to those skilled in the art through logic analysis, reasoning and limited experiments based on the prior art according to the concept of the present invention should be within the scope of protection defined by the claims.
Claims (8)
1. The face cream is characterized by comprising the following components in parts by weight:
phase A: 0.2-0.3 part of decadiene cross-linked polymer;
18-22 parts of water; 20.7968 parts
Phase B: 0.4-0.8 parts of fucoidin;
0.05-0.08 part of fermented olive oil;
and (3) phase O: 0.5-0.8 part of hydrogenated polydecene;
0.5-0.8 part of squalane;
0.5-0.8 part of macadamia nut oil;
1-1.5 parts of shea butter;
0.2-0.5 part of mixed alcohol;
0.15-0.5 part of cyclopentadimethylsiloxane and/or cyclohexasiloxane;
0.2-0.4 part of dimethyl silicone oil;
0.1-0.3 part of cetearyl alcohol;
hydrogenated lecithin 0.1-0.3;
1-1.5 of glycerol stearate;
phase W: 0.004-0.008 parts of hyaluronic acid;
1-1.5 parts of propylene glycol;
1-1.5 parts of butanediol;
0.1-0.5 part of glucan;
phase H: 0.2-0.4 parts of Hibiscus thunbergii extract;
0.1-0.2 parts of palmitoyl tripeptide, palmitoyl tetrapeptide and/or palmitoyl pentapeptide;
0.01-0.03 part of essence;
0.01-0.02 part of potassium hydroxide;
1-1.5 parts of polycarbonate.
2. The cream of claim 1, wherein: in the phase A, 0.264 part of decadiene cross-linked polymer and 20.7968 parts of water are used.
3. The cream of claim 1, wherein: and in the phase B, 0.64 part of fucoidin and 0.064 part of fermented olive oil are added.
4. The cream of claim 1, wherein: in the O phase, 0.64 part of hydrogenated polydecene, 0.64 part of squalane, 0.64 part of macadamia nut oil, 1.28 parts of shea butter, 0.32 part of mixed alcohol, 0.32 part of cyclopenta dimethyl silicone and/or cyclohexasiloxane, 0.32 part of dimethyl silicone oil, 0.16 part of cetearyl alcohol, 0.16 part of hydrogenated lecithin and 1.28 parts of glycerol stearate.
5. The cream of claim 1, wherein: in the W phase, 0.0064 parts of hyaluronic acid, 1.28 parts of propylene glycol, 1.28 parts of butanediol and 0.32 part of glucan.
6. The cream of claim 1, wherein: in the H phase, 0.32 part of the extract of the plectropodium nigricans, 0.16 part of palmitoyl tripeptide and/or palmitoyl tetrapeptide and/or palmitoyl pentapeptide, 0.016 part of essence, 0.0128 part of potassium hydroxide and 1.28 parts of polycarbonate.
7. A method of preparing a facial cream as claimed in any one of claims 1 to 6, comprising the steps of:
(1) adding the phase A into a main kettle, uniformly stirring and completely dissolving, adding the phase W into the main kettle, stirring and dissolving, adding the phase O into the main kettle, and heating the main kettle to 80-85 ℃;
(2) maintaining the temperature of the main kettle at 80-85 ℃, and preserving the temperature for 20 minutes;
(3) cooling the main kettle to 60 ℃, adding the phase B, and stirring for 10 minutes;
(4) cooling the main kettle to 45 ℃, adding the H material, and stirring for 10 minutes;
(5) then the pH value is measured to be qualified after the temperature is reduced to 36 ℃.
8. The method for preparing the face cream as claimed in claim 7, which is characterized in that: in the step (5), the qualified pH value is 3.5-6.3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011370386.7A CN112353707A (en) | 2020-11-30 | 2020-11-30 | Face cream and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011370386.7A CN112353707A (en) | 2020-11-30 | 2020-11-30 | Face cream and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112353707A true CN112353707A (en) | 2021-02-12 |
Family
ID=74536418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011370386.7A Pending CN112353707A (en) | 2020-11-30 | 2020-11-30 | Face cream and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112353707A (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1328813A (en) * | 2000-06-20 | 2002-01-02 | 协和发酵工业株式会社 | Cosmetics |
| CN102058494A (en) * | 2009-11-18 | 2011-05-18 | 信越化学工业株式会社 | Cosmetic |
| CN102665669A (en) * | 2009-11-26 | 2012-09-12 | 巴斯夫欧洲公司 | Use of hyperbranched polycarbonates in cosmetic and dermatological formulations |
| CN104784074A (en) * | 2015-04-01 | 2015-07-22 | 珀莱雅化妆品股份有限公司 | Cationic nano emulsion with anti-allergic effect and preparation method of cationic nano emulsion |
| CN109846748A (en) * | 2018-11-02 | 2019-06-07 | 上海珈凯生物科技有限公司 | A kind of moisturiser containing black phycocolloid and preparation method thereof, application |
| CN110812305A (en) * | 2019-12-17 | 2020-02-21 | 广州市澳莱化妆品有限公司 | Anti-wrinkle eye cream and preparation process thereof |
| CN111449984A (en) * | 2020-04-02 | 2020-07-28 | 广州市逸轩精细化工有限公司 | Moisturizing essence cream and preparation method thereof |
| CN111588648A (en) * | 2020-05-22 | 2020-08-28 | 广东创美抗衰老研究有限公司 | Autophagy rejuvenation anti-aging cream |
-
2020
- 2020-11-30 CN CN202011370386.7A patent/CN112353707A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1328813A (en) * | 2000-06-20 | 2002-01-02 | 协和发酵工业株式会社 | Cosmetics |
| CN102058494A (en) * | 2009-11-18 | 2011-05-18 | 信越化学工业株式会社 | Cosmetic |
| CN102665669A (en) * | 2009-11-26 | 2012-09-12 | 巴斯夫欧洲公司 | Use of hyperbranched polycarbonates in cosmetic and dermatological formulations |
| CN104784074A (en) * | 2015-04-01 | 2015-07-22 | 珀莱雅化妆品股份有限公司 | Cationic nano emulsion with anti-allergic effect and preparation method of cationic nano emulsion |
| CN109846748A (en) * | 2018-11-02 | 2019-06-07 | 上海珈凯生物科技有限公司 | A kind of moisturiser containing black phycocolloid and preparation method thereof, application |
| CN110812305A (en) * | 2019-12-17 | 2020-02-21 | 广州市澳莱化妆品有限公司 | Anti-wrinkle eye cream and preparation process thereof |
| CN111449984A (en) * | 2020-04-02 | 2020-07-28 | 广州市逸轩精细化工有限公司 | Moisturizing essence cream and preparation method thereof |
| CN111588648A (en) * | 2020-05-22 | 2020-08-28 | 广东创美抗衰老研究有限公司 | Autophagy rejuvenation anti-aging cream |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106236675B (en) | Skin care matrix with moisturizing and anti-aging effects and preparation and application thereof | |
| CN103520058B (en) | Silkworm chrysalis active polypeptide after-sun repairing gel and preparation method thereof | |
| CN107898721B (en) | Skin-care matrix and application thereof | |
| CN107961208B (en) | Micromolecular beautifying and tightening spray and preparation method thereof | |
| CN110478305A (en) | A kind of preparation process and its application of sheep placenta extract | |
| CN109730953A (en) | A kind of hyaluronic acid (sodium hyaluronate) stoste and preparation method thereof | |
| CN111329780A (en) | Moisturizing and repairing facial cream capable of tightening wrinkles and preparation method thereof | |
| CN111603434A (en) | Composition for improving skin wrinkles and cosmetic thereof | |
| CN110496067A (en) | A kind of anti-wrinkle composition and its preparation method and application | |
| CN112426379A (en) | Preparation method of polypeptide wrinkle-removing repair essence | |
| CN110917055A (en) | Oligopeptide repair essence and preparation process thereof | |
| CN110585111A (en) | Anti-aging cosmetic additive and preparation method thereof | |
| CN110917109A (en) | Anti-aging mask | |
| CN113768853B (en) | Whitening and freckle-removing composition, and preparation method and application thereof | |
| CN107837223B (en) | Facial mask essence containing dendrobium officinale extract, facial mask containing dendrobium officinale extract, preparation method of facial mask essence and application of facial mask essence | |
| CN107961198A (en) | Eye cream containing stem cell secretory factors | |
| CN107753380A (en) | A kind of eyebrow, which increases, promotes formula of liquid | |
| JP2001518910A (en) | Use of at least one protein fraction extracted from Hibiscus esculentus seed and cosmetic compositions comprising such a fraction | |
| CN112353707A (en) | Face cream and preparation method thereof | |
| CN110840786A (en) | Blue copper peptide essence and preparation method thereof | |
| CN107753389A (en) | A kind of recombined collagen foaming pectin facial mask and preparation method thereof | |
| JPS6368514A (en) | Cosmetic containing vegetable polypeptide derivative | |
| CN112370378A (en) | Cosmetic containing guayule troponin stock solution and preparation method thereof | |
| JP2004532895A (en) | Method for preparing hydrolyzed jojoba protein and formulations containing hydrolyzed jojoba protein | |
| CN110812317A (en) | Skin care product with effects of moisturizing epidermis and resisting wrinkles of skin and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210212 |
|
| RJ01 | Rejection of invention patent application after publication |